Oxford COVID-19 vaccine may become the first to get Indian regulator s nod for emergency use
Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the CDSCO will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.The process of granting emergency use approval for Bharat Biotechs COVID-19 vaccine Covaxin may take time as its phase 3 trials are still underway, while Pfizer is yet to make a presentation.PTI | New Delhi | Updated: 26-12-2020 17:15 IST | Created: 26-12-2020 17:08 IST
New Delhi | Jagran News Desk: Days after Union Health Dr Harsh Vardhan said that India will roll out its first COVID-19 vaccine in January, a media report has claimed that Oxford vaccine Covishield will likely become the first vaccine to be rolled out in the country.
News agency PTI quoted government sources saying that if Oxford vaccine gets approval in the United Kingdom (UK) next week, then the Centre will likely give a nod to Serum Institute of India (SII) for emergency use authorisation in India.
However, the government sources told PTI that the Centre will hold a meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine.
URL copied
Oxford COVID-19 vaccine Covishield likely to be the first to get approval in India
With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots here.
Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the CDSCO will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here, official sources said.
Oxford vaccine may become the first to get Indian regulator s nod for emergency use PTI
Updated : Dec 26, 2020, 10:09 pm IST
The Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week
An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca.(AFP)
New Delhi: With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots here.